| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -216,028 | -149,524 | -67,574 | -257,011 |
| Depreciation and amortization | 21,770 | 13,949 | 6,605 | 15,855 |
| Net accretion of discounts on marketable securities | 17,859 | 12,799 | 6,847 | 29,561 |
| Amortization of debt issuance costs | 2,870 | 1,902 | 945 | 2,870 |
| Amortization of deferred contract acquisition costs | 43,462 | 28,254 | 13,931 | 40,045 |
| Non-cash operating lease costs | 3,210 | 2,164 | 1,075 | 2,794 |
| Lease abandonment charges | - | - | - | 0 |
| Stock-based compensation, net of amounts capitalized | 295,700 | 194,572 | 92,575 | 292,736 |
| Deferred income taxes | -16,851 | -17,161 | -17,338 | 231 |
| Other | -4,586 | -1,561 | -454 | -1,695 |
| Accounts receivable | 44,616 | 44,907 | -15,414 | 50,235 |
| Deferred contract acquisition costs | 45,085 | 25,646 | 10,410 | 37,272 |
| Prepaid expenses and other assets | 29,686 | 18,473 | -1,515 | 361 |
| Accounts payable | 4,573 | 4,082 | -1,274 | 8,286 |
| Accrued expenses and other liabilities | -43,373 | -28,679 | -49,828 | -7,222 |
| Operating lease liabilities | -6,573 | -4,382 | -2,177 | -5,949 |
| Deferred revenue | 66,062 | 46,448 | -3,820 | 21,348 |
| Net cash provided by (used in) operating activities | 22,162 | -8,639 | -26,754 | -1,751 |
| Capitalization of internal-use software costs | 16,406 | 10,997 | 4,806 | 15,984 |
| Purchases of marketable securities | 1,286,190 | 871,228 | 405,235 | 1,172,359 |
| Sales of marketable securities | 6,144 | 6,144 | - | 12,744 |
| Maturities of marketable securities | 1,133,114 | 757,937 | 299,467 | 1,210,037 |
| Purchases of investments in privately-held companies | 750 | 0 | - | 2,250 |
| Purchases of property and equipment | 3,155 | 2,348 | 1,429 | 1,898 |
| Cash paid for business combinations, net of cash acquired | 0 | - | - | 115,516 |
| Net cash used in investing activities | -167,243 | -120,492 | -112,003 | -85,226 |
| Proceeds from issuance of common stock upon exercise of vested options | 32,709 | 22,668 | 16,606 | 36,332 |
| Repurchases of unvested common stock | - | - | - | 0 |
| Proceeds from issuance of common stock under employee stock purchase plan | 23,926 | 14,195 | 14,195 | 23,970 |
| Net cash provided by financing activities | 56,635 | 36,863 | 30,801 | 60,302 |
| Effect of exchange rate changes on cash and cash equivalents | 1,003 | 1,879 | 537 | -480 |
| Net decrease in cash and cash equivalents | -87,443 | -90,389 | -107,419 | -27,155 |
| Cash and cash equivalents at beginning of period | 385,980 | 385,980 | 385,980 | 349,761 |
| Cash and cash equivalents at end of period | 298,537 | 295,591 | 278,561 | 322,606 |
Confluent, Inc. (CFLT)
Confluent, Inc. (CFLT)